IRESSA 250 MG
géfitinib
Public price
9.355,00 MAD
Active substance
géfitinib
Laboratory
MAPHAR
What is this medicine?
Gefitinib is a tyrosine kinase inhibitor used for the first-line treatment of specific metastatic non-small cell lung cancer.
Verified summary
géfitinib, Comprimé pelliculé, 250 MG, Boite de 30
Common uses
First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations.
Class
Tyrosine kinase inhibitor
Laboratory
MAPHAR
Hospital price
9.180,00 MAD
Strength
250 MG
Form
Comprimé pelliculé
Presentation
Boite de 30
ATC code
L01XE02
Type
Princeps
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 9.355,00 MAD